In conclusion, this study demonstrates, for the first time, that piperine can ameliorate AD-like symptoms by reducing Th2-associated immune responses in a TMA-induced mouse model, and it is able to regulate STAT6 phosphorylation induced by IL-4-mediated responses in CD4+ T cells and keratinocytes. Here, IL4 is linked to Alzheimer disease.